Midgard Science

FyoniBio

Berlin, Germany fyonibio.com

From their website, Nov 2026

Work here? Claim this listing

About

FyoniBio develops biologics and provides bioanalytical support for clinical trials and biologic characterization. It works with biopharmaceutical programs from discovery and cell line development through process development, analytics, and clinical bioanalysis. The company is based in Berlin, Germany.

Services

  • Cell Line Development

    Develops mammalian cell lines for biotherapeutics using CHO and human platforms, including tailored expression systems for complex molecules.

    Cell line development

  • CHOFlow® Cell Line Development

    Provides a glycoengineered CHO platform for producing afucosylated monoclonal antibodies and other glycoproteins with enhanced ADCC.

    Cell line development

  • CHOnamite® Cell Line Development

    Offers a CHO-based platform for high-yield production of biotherapeutics and classical mAb glycosylation.

    Cell line development

  • GlycoExpress® Cell Line Development

    Provides a human expression platform for proteins that require authentic human post-translational modifications and complex glycosylation.

    Cell line development

  • Process Development

    Supports upstream and downstream process development and optimization to prepare biologics for scalable manufacturing.

  • Analytical Services and Bioassays

    Performs biochemical analytics and bioassay development to characterize biologics across development stages.

    Assays & in vitro testing

  • Mass Spectrometry Analytics

    Uses mass spectrometry for characterization of critical quality attributes such as glycosylation, integrity, and PTMs.

    Assays & in vitro testing

  • Clinical Bioanalysis

    Develops and runs bioanalytical methods for PK, PD, and immunogenicity studies in clinical samples.

    ADME, DMPK & toxicology

  • Functional and Potency Bioassays

    Develops and validates functional and potency assays for biologics.

    Assays & in vitro testing

  • Bioanalytical Support for Clinical Trials

    Provides GCLP-compliant bioanalysis of clinical samples for Phase I to IV studies.

    ADME, DMPK & toxicology

  • Bioanalytical Characterization

    Characterizes biologics from feasibility through regulatory submission using analytical and functional methods.

    Assays & in vitro testing

Turnaround
Typically respond within 24 hours
What to send
Blood-derived matrices like serum and plasma · Tissue-based materials

Capabilities

Assays and studies
Bioanalysis · Process development · Antibodies · Immunogenicity · Oligonucleotides · CHO · PK/PD · ADCs · LC-MS/MS · Cell-based assays · PK assays · PD assays
12 moreImmunogenicity assays · ADA assays · Neutralizing antibody assays · Biomarker analysis · SNP analysis · Immune cell profiling · Functional assays · Ligand binding assays · Hybrid LC-MS/MS methods · SEC · WCX/WAX · RPC
Scale and capacity
Analysis capacity of up to 10,000 samples per year · High yields > 12 g/L for some mAbs · High yields > 5 g/L in standard fed-batch processes · Stability over > 70 population doublings
Therapeutic areas
Immuno-oncology

Instruments and platforms

  • LC-MS
  • Octet BLI
  • DRX2
  • AlphaScreen
  • TÜV Rheinland

Modalities and species

Modalities
Antibody · Bispecific · ADC · Oligonucleotide · Recombinant protein · Biosimilar
Species and models
CHO-K1 · CHO-GS-KO · CHO-DG44 · Human cell lines · FcγRIIIa · NK cells

Certifications

As the company states them, with the certificate or registry record where there is one.

  • ISO 9001:2015Self-reported

    Scope: quality management systems

  • GMPSelf-reported

Company

Type
CRDMO
Founded
2022

Locations

Based in
Berlin, Germany
Sites
Berlin, Germany
Serves
global

Contacts

Similar labs

Work here? Claim this listing